Skip to main content

Concierge hepatology imaging · London

Perspectum LiverMultiScan, multiparametric MRI that quantifies liver fibrosis, inflammation and fat in one scan.

Perspectum LiverMultiScan is a multiparametric MRI (cT1, T2*, PDFF) that quantitatively measures liver fibrosis-inflammation (cT1), iron (T2*) and fat (PDFF) — a non-invasive alternative to liver biopsy in MASLD / MASH assessment.

See indicative pricing
A consultant radiologist reviewing a Perspectum LiverMultiScan in a private London clinic

Why patients choose us

  • 01

    The right hands

    A consultant hepatologist and a consultant radiologist read the LiverMultiScan together — biopsy-quality answers without the biopsy.

  • 02

    Quantitative, repeatable

    cT1, T2* and PDFF are numbers, not opinions — the same metrics on the same scanner track your liver over time.

  • 03

    Independent, and free

    We are paid by no clinic, so the recommendation is impartial and costs you nothing.

Indicative pricing

What a private LiverMultiScan costs in London.

Indicative ranges across our partner clinics. Send the details and we quote firm figures across two or three options.

In short

A standard LiverMultiScan in our network: £850–£1,200, with a full hepatologist report within 5–7 working days.

Scan type Indicative range
Standard LiverMultiScan MRI £850–£1,200
LiverMultiScan + hepatology consultation £1,100–£1,600
LiverMultiScan + FibroScan pairing £1,050–£1,500
Serial monitoring LiverMultiScan (6–12 month follow-up) £800–£1,150
Full MASLD / MASH work-up (LMS + bloods + FibroScan + clinic) £1,500–£2,400
Urgent LiverMultiScan (within 5 working days) £1,000–£1,500

Prices vary by clinic, whether a hepatologist consultation or FibroScan pairing is included, and whether the case is expedited. We come back with a firm quote within one working day.

Key facts

LiverMultiScan, in six lines.

What the scan is, what it isn’t, and where it sits alongside FibroScan, FIB-4 and biopsy.

  • What it is

    A multiparametric liver MRI reporting cT1, T2* and PDFF metrics in a single, non-contrast scan.

  • Non-invasive alternative to biopsy

    Quantifies fibro-inflammation, iron and fat without a needle — a real alternative to liver biopsy in most MASLD pathways.

  • Quantitative, not descriptive

    Detects fibro-inflammation, iron and fat as numbers you can track — not adjectives that drift between reports.

  • Complements FibroScan and FIB-4

    Sits alongside transient elastography and serum scores — useful when those tests are borderline or discordant.

  • CE-marked, validated

    A CE-marked device with a substantial peer-reviewed evidence base in MASLD, MASH and iron overload.

  • Reported by hepatologist + radiologist

    A consultant hepatologist interprets the metabolic picture; a consultant radiologist reads the images.

The journey

From hepatology consult to report — what happens, in order.

A consultant hepatologist frames the question; the MRI answers it; a plan follows — usually within one to two weeks.

  1. 01

    Before

    Hepatology consultation

    A consultant hepatologist reviews your history, bloods and prior imaging, and confirms LiverMultiScan is the right next step.

  2. 02

    Before

    No fasting required

    Eat, drink and take medication as normal. Wear something without metal fastenings for the MRI room.

  3. 03

    On the day

    MRI acquisition (15–25 min)

    You lie flat in a 1.5T or 3T scanner. Breath-holds are short and coached; no contrast is given.

  4. 04

    On the day

    Sequences: cT1, T2*, PDFF

    Three quantitative sequences map fibro-inflammation (cT1), iron (T2*) and fat fraction (PDFF) across the whole liver.

  5. 05

    After

    AI post-processing (Perspectum cloud)

    Images are uploaded to the Perspectum cloud, where a validated pipeline generates the quantitative maps and metrics.

  6. 06

    After

    Consultant hepatologist review

    A hepatologist reads the metrics alongside your bloods, FibroScan and FIB-4 — not in isolation.

  7. 07

    After

    Personalised plan

    A written report and a plan you can act on — lifestyle, pharmacotherapy, or repeat monitoring — tailored to your numbers.

Typical end-to-end: 7–14 days. Urgent cases: within a week.

What it shows

The three metrics — and what they answer.

LiverMultiScan answers three specific questions — fibro-inflammation, iron and fat — and lets you track each one over time.

  • cT1 (fibro-inflammation)

    Iron-corrected T1 — the quantitative marker of combined liver fibrosis and inflammation.

  • T2* (iron overload)

    Detects and quantifies iron loading — the same physics as the accepted FerriScan pathway.

  • PDFF (steatosis %)

    Proton density fat fraction — a precise percentage of liver fat, whole-liver rather than a single core.

  • MASLD / MASH classification

    Puts the three metrics together to stratify metabolic-associated steatotic liver disease and MASH risk.

  • Iron overload monitoring

    Tracks hepatic iron in haemochromatosis, transfusion dependence and chronic liver disease.

  • Response to therapy

    Objective, quantitative change in cT1 and PDFF after lifestyle, GLP-1 or MASH-directed pharmacotherapy.

  • Baseline for serial monitoring

    A reproducible starting point — the same metrics on the same scanner give a real trend, not a guess.

  • Red flag: high cT1 + high PDFF — hepatology MDT review

    Combined elevation warrants urgent hepatology MDT input, not another scan.

Treatment options

What the numbers usually lead to.

Where LiverMultiScan actually changes the plan — from lifestyle through pharmacotherapy to structured hepatology follow-up.

  • Lifestyle intervention

    Structured weight loss, dietary change and alcohol reduction — still the highest-yield first step in MASLD.

  • Metabolic risk optimisation

    Tight control of type 2 diabetes, dyslipidaemia, hypertension and sleep apnoea — the drivers behind the liver picture.

  • MASH-directed pharmacotherapy

    Consideration of resmetirom and emerging MASH-specific agents where cT1 and PDFF meet treatment thresholds.

  • Weight-loss medication (GLP-1)

    GLP-1 receptor agonists where obesity and metabolic risk dominate — with liver metrics tracked over time.

  • Bariatric surgery discussion

    A multidisciplinary referral where BMI, comorbidities and fibro-inflammation together justify a surgical route.

  • Anti-inflammatory therapy trials

    Access to appropriate MASH and NASH trials for patients whose metrics qualify.

  • Repeat LiverMultiScan monitoring

    Serial LiverMultiScan at 6–12 months to quantify real response — not descriptive follow-up.

  • Structured hepatology follow-up

    Consultant-led hepatology follow-up with a written plan you and your GP can act on.

Our vetted London network

A small panel of clinics, we picked them.

Perspectum-accredited sites across central London — introductions are made privately, once we understand your case.

Selection criteria

How we choose every clinic in our network.

A modern London MRI suite with a current-generation 3T scanner
Consultant hepatologists and radiologists
  • Consultant hepatologists and consultant radiologists reading together

  • Perspectum-accredited scanning protocol on validated 1.5T or 3T platforms

  • Structured written report within 5–7 working days

  • Onward hepatology MDT pathway if advanced fibro-inflammation is found

Red flags

When the metrics change the pathway.

LiverMultiScan is a safe, non-contrast MRI. What matters is when the findings should bypass routine follow-up and go straight to a specialist route.

  • Advanced fibro-inflammation (high cT1)

    Persistently elevated cT1 warrants urgent consultant hepatology review and consideration for MASH-directed therapy.

  • Iron overload (haemochromatosis)

    Elevated hepatic iron on T2* triggers a haematology / hepatology work-up and, where appropriate, venesection.

  • Severe steatosis (PDFF > 20%)

    High-grade steatosis needs a structured metabolic plan and monitoring — not reassurance alone.

  • Concurrent decompensated liver disease

    Ascites, encephalopathy or jaundice change the pathway — hospital-based hepatology, not concierge imaging.

  • HCC on imaging

    A focal lesion suspicious for hepatocellular carcinoma bypasses routine follow-up and goes straight to an HPB MDT.

  • MASH with fibrosis F3–F4

    Advanced fibrosis needs a specialist hepatology pathway with surveillance for varices and HCC.

  • Failed lifestyle intervention

    Where lifestyle has not moved the numbers, pharmacotherapy or bariatric routes deserve honest discussion.

  • Post-transplant graft dysfunction

    LiverMultiScan is not a substitute for the transplant team’s protocols — findings are shared with the graft centre.

  • Alcohol relapse

    Any relapse changes both the imaging interpretation and the plan — declare it, so the pathway matches reality.

Reading your report

A LiverMultiScan report can look intimidating. It isn’t.

Whatever the finding, the report keeps to the same four parts.

A consultant hepatologist reviewing a Perspectum LiverMultiScan report on a clinical workstation at a UK private clinic

A quiet reminder

The report is written for your doctor, not for you — and that’s normal.

If you would like us to talk you through it before your follow-up, just ask.

  1. 01 Header

    Indication and metabolic context

    Your details, the reason for the scan, and the bloods, FibroScan and FIB-4 that shape interpretation.

  2. 02 Technique

    Scanner, protocol and sequences

    Platform, field strength and the cT1, T2* and PDFF sequences acquired, plus the Perspectum pipeline version.

  3. 03 Findings

    cT1, T2* and PDFF metrics

    The three quantitative metrics — with reference ranges and any focal lesions described alongside.

  4. 04 Impression

    The conclusion: read this first

    MASLD / MASH stratification, iron status, steatosis grade and the concrete next step.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover depends on your policy and clinic; we confirm with your insurer before booking.

Frequently asked

Everything we get asked about LiverMultiScan.

Quick answers on how LiverMultiScan sits alongside FibroScan, FIB-4 and biopsy — and how the report translates into a plan.

  • What is Perspectum LiverMultiScan?

    A multiparametric liver MRI that quantifies three things in a single, non-contrast scan: cT1 (fibro-inflammation), T2* (iron) and PDFF (fat). The images are processed through Perspectum’s validated cloud pipeline and reported by a consultant hepatologist alongside a consultant radiologist.

  • Is LiverMultiScan a real alternative to liver biopsy?

    For most MASLD and MASH pathways, yes — it gives a quantitative, whole-liver readout rather than a single 1/50,000th core. Biopsy remains the reference standard for specific indications, but many patients now avoid it entirely by combining LiverMultiScan with FibroScan and serum scores.

  • How is LiverMultiScan different from FibroScan and FIB-4?

    FibroScan measures liver stiffness at a single point; FIB-4 is a blood-based score. LiverMultiScan measures fibro-inflammation, iron and fat across the whole liver. The three are complementary — LiverMultiScan is particularly useful when FibroScan and FIB-4 are borderline or disagree.

  • Do I need contrast, or to fast?

    No contrast is given, and you don’t need to fast. Wear clothing without metal fastenings and expect coached breath-holds during the scan.

  • How long does the scan take, and when do I get the report?

    The MRI itself is 15–25 minutes. Images are processed through the Perspectum cloud and a written report from your hepatologist typically follows within 5–7 working days.

  • How often should LiverMultiScan be repeated?

    For active MASLD or MASH under treatment, a repeat at 6–12 months is common — the metrics are designed to be tracked. Your hepatologist sets the interval based on your baseline numbers and treatment plan.

WhatsApp Call us

In practice, in London

What perspectum liver multiparametric MRI looks like on the ground in London

With perspectum liver multiparametric MRI, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. On the NHS, perspectum liver multiparametric MRI typically sits behind a triage step and a wait that can stretch from a few weeks into months. In London’s private sector, the same appointment often lands within days. That speed matters when symptoms are disrupting work, sleep, or a plan you’d already committed to — and it’s the single most common reason people call us in the first place.

A private perspectum liver multiparametric MRI pathway in London usually looks like this: an initial consultation, any diagnostics booked at a nearby facility (most within Zone 1 or 2), and a written report sent to you and your GP within a few days. The consultants we work with hold NHS posts alongside their private lists, which keeps the standards consistent across both settings. For perspectum liver multiparametric MRI specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

Where a good concierge earns its keep is in the matching. There are dozens of consultants in London who see perspectum liver multiparametric MRI — but not all of them are the right fit for every case. We narrow it down based on subspecialty, insurer coverage, the specific question being asked, and whether continuity into treatment matters. The right first appointment saves you from repeating yourself later.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

Confidential. We respond within one working day.